These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35915501)

  • 1. The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middle-income countries-a review of the current literature.
    George C; Echouffo-Tcheugui JB; Jaar BG; Okpechi IG; Kengne AP
    BMC Med; 2022 Aug; 20(1):247. PubMed ID: 35915501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease in low-income to middle-income countries: the case for increased screening.
    George C; Mogueo A; Okpechi I; Echouffo-Tcheugui JB; Kengne AP
    BMJ Glob Health; 2017; 2(2):e000256. PubMed ID: 29081996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Kidney Disease in Low- and Middle-Income Countries.
    Kalyesubula R; Conroy AL; Calice-Silva V; Kumar V; Onu U; Batte A; Kaze FF; Fabian J; Ulasi I
    Semin Nephrol; 2022 Sep; 42(5):151315. PubMed ID: 37001337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organization and Structures for Detection and Monitoring of CKD Across World Countries and Regions: Observational Data From a Global Survey.
    Tungsanga S; Fung W; Okpechi IG; Ye F; Ghimire A; Li PK; Shlipak MG; Tummalapalli SL; Arruebo S; Caskey FJ; Damster S; Donner JA; Jha V; Levin A; Saad S; Tonelli M; Bello AK; Johnson DW
    Am J Kidney Dis; 2024 Oct; 84(4):457-468.e1. PubMed ID: 38788792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for hyperglycemia in the developing world: rationale, challenges and opportunities.
    Echouffo-Tcheugui JB; Mayige M; Ogbera AO; Sobngwi E; Kengne AP
    Diabetes Res Clin Pract; 2012 Nov; 98(2):199-208. PubMed ID: 22975016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries.
    Tonelli M; Dickinson JA
    J Am Soc Nephrol; 2020 Sep; 31(9):1931-1940. PubMed ID: 32839279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019.
    Ke C; Liang J; Liu M; Liu S; Wang C
    BMC Nephrol; 2022 Jan; 23(1):17. PubMed ID: 34986789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of chronic kidney disease among at-risk adults in rural Guatemala.
    Nandi M; Kurschner S; Wilcox K; Flood D; Mendoza Montano C; Barnoya J; Rohloff P; Chary A
    Glob Public Health; 2021 Apr; 16(4):623-638. PubMed ID: 33161879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and early detection of chronic kidney disease at primary healthcare.
    Nagib SN; Abdelwahab S; Amin GEE; Allam MF
    Clin Exp Hypertens; 2021 Jul; 43(5):416-418. PubMed ID: 33726610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of diagnostic and prognostic models of chronic kidney disease in low-income and middle-income countries.
    Aparcana-Granda DJ; Ascencio EJ; Carrillo Larco RM
    BMJ Open; 2022 Mar; 12(3):e058921. PubMed ID: 35292503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of chronic kidney disease stages 3-5 in low- and middle-income countries in Asia: A systematic review and meta-analysis.
    Suriyong P; Ruengorn C; Shayakul C; Anantachoti P; Kanjanarat P
    PLoS One; 2022; 17(2):e0264393. PubMed ID: 35213610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review.
    Gheewala PA; Zaidi STR; Jose MD; Bereznicki L; Peterson GM; Castelino RL
    J Nephrol; 2018 Feb; 31(1):27-36. PubMed ID: 28181150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of participants in the KEEP Mexico's chronic kidney disease screening program.
    Obrador GT; Villa AR; Olvera N; Gutiérrez V; Contreras D; Reyes R
    Arch Med Res; 2013 Nov; 44(8):650-4. PubMed ID: 24211753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at estimating glomerular filtration rate in adults with diabetes mellitus: a systematic review and meta-analysis protocol.
    Zafari N; Churilov L; MacIsaac RJ; Torkamani N; Baxter H; Kiburg KV; Ekinci E
    BMJ Open; 2019 Aug; 9(8):e031558. PubMed ID: 31473625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Existing Care Models for Chronic Kidney Disease in Low- and Middle-Income Countries: A Systematic Review.
    Nkunu V; Wiebe N; Bello A; Campbell S; Tannor E; Varghese C; Stanifer J; Tonelli M
    Can J Kidney Health Dis; 2022; 9():20543581221077505. PubMed ID: 35251672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of screening for Chronic Kidney Disease.
    Djukanović Lj
    Prilozi; 2010; 31(1):249-59. PubMed ID: 20693945
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.